21.5
Outlook Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
27.5
FY23:
31.0
FY24:
27.4
FY25:
17.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.30
FY22:
1.01
FY23:
1.32
FY24:
1.41
FY25:
1.20
Total assets
Change from FY21 to FY25
millions USD
FY21:
22.8
FY22:
28.5
FY23:
32.3
FY24:
28.8
FY25:
18.6
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.75
FY22:
19.7
FY23:
46.7
FY24:
42.6
FY25:
45.8
(negative)
Change from FY21 to FY25
millions USD
FY21:
11.5
FY22:
0.06
FY23:
0.01
FY24:
59.3
FY25:
4.96
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.61
FY22:
8.74
FY23:
−14.4
FY24:
−73.1
FY25:
−32.2
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
22.8
FY22:
28.5
FY23:
32.3
FY24:
28.8
FY25:
18.6
All amounts in millions USD